Skip to main content
. Author manuscript; available in PMC: 2020 Mar 20.
Published in final edited form as: Brain Res. 2019 Apr 16;1731:146222. doi: 10.1016/j.brainres.2019.04.017

Fig. 4.

Fig. 4.

Effects of SB-334867 on motivational parameters in the stop signal task. Effects of acute administration of the OxR1 antagonist SB-334867 or its vehicle on (A) the rate of trial execution, (B) the % of trials omitted and (C) the median latency to collect rewards during correct trials. For the baseline measurement, data from the training sessions immediately preceding the 3 test days was averaged. Error bars represent standard error of the mean, while open circles represent data from individual rats (N = 21). **p < 0.005 as compared to vehicle treatment.